Original paper
Empagliflozin in patients with heart failure and reduced ejection fraction
Abstract
Background: Sodium–Glucose Cotransporter 2 (SGLT2) inhibitors reduce the risk of a first
null hospitalization for heart failure in type 2 diabetics. But data regarding role of SGLT2 inhibitors in
null HFrEF is limited.
Methods: In this prospective small centre trial, we randomly assigned 822 patients in class II, III,
null NYHA and an ejection fraction of 35% or less to receive either empagliflozin or placebo, in addition
null to...
Paper Details
Title
Empagliflozin in patients with heart failure and reduced ejection fraction
Published Date
Jan 1, 2020
Journal
Volume
12
Issue
7
Pages
186
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History